Cargando…
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation
BACKGROUND: A standard therapy for locally advanced rectal cancer (LARC) includes fluoropyrimidine (FP)-based neoadjuvant chemoradiation (nCRT). Previous studies have inconsistently demonstrated that baseline neutrophil- and platelet-to-lymphocyte ratios (NLR and PLR) are predictive of response to n...
Autores principales: | Dudani, Shaan, Marginean, Horia, Tang, Patricia A., Monzon, Jose G., Raissouni, Soundouss, Asmis, Timothy R., Goodwin, Rachel A., Gotfrit, Joanna, Cheung, Winson Y., Vickers, Michael M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612202/ https://www.ncbi.nlm.nih.gov/pubmed/31277604 http://dx.doi.org/10.1186/s12885-019-5892-x |
Ejemplares similares
-
The Impact of Chronic Kidney Disease in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation
por: Dudani, Shaan, et al.
Publicado: (2021) -
The impact of driving time, distance, and socioeconomic factors on outcomes of patients with locally advanced rectal cancer
por: Gotfrit, Joanna, et al.
Publicado: (2020) -
Acute liver failure and seizures as a consequence of regorafenib exposure in advanced rectal cancer
por: Raissouni, Soundouss, et al.
Publicado: (2015) -
Evaluation of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio on Predicting Responsiveness to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients
por: Liu, Maoxi, et al.
Publicado: (2022) -
Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation
por: Shen, Lijun, et al.
Publicado: (2014)